HAART May Not Be Enough to Normalize Immune Aging in Women, Study Finds
A Poster Spotlight From CROI 2012
March 7, 2012
In this analysis of data from the historic Women's Interagency HIV Study, HAART decreased immune activation, exhaustion, senescence, and apoptosis in CD8+ T cells (cohort mean age: 41.2 years). However, these levels did not become normalized even after a year of HAART. Therapies that reverse immune system aging used in combination with HAART may be warranted, the research suggests.
For more information, read CROI poster 331, "Impact of HAART Initiation on Immune Regulation in Aging HIV+ Women: Women's Interagency HIV Study," presented by Seema Desai.
Copyright © 2012 Remedy Health Media, LLC. All rights reserved.
The Effects of Injectable Hormonal Contraceptives on HIV Seroconversion and on Sexually Transmitted Infections
This article was provided by TheBodyPRO. It is a part of the publication The 19th Conference on Retroviruses and Opportunistic Infections.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.